Key Insights
The UK ophthalmic industry is poised for robust growth, driven by an aging population, increasing prevalence of eye conditions, and advancements in diagnostic and treatment technologies. The market is currently valued at an estimated £2,779.67 million in 2024, projecting a healthy compound annual growth rate (CAGR) of 6.1% through 2033. Key drivers include the rising incidence of age-related macular degeneration (AMD), glaucoma, and cataracts, which necessitate advanced surgical interventions and sophisticated diagnostic tools. The demand for vision correction devices, including specialized contact lenses and advanced intraocular lenses (IOLs), also significantly contributes to market expansion. Furthermore, a growing awareness of eye health and regular eye examinations among the UK population fuels the adoption of diagnostic and monitoring devices. Innovation in laser technology for refractive surgery and glaucoma treatment is also a prominent trend, offering less invasive and more effective solutions for patients.
UK Ophthalmic Industry Market Size (In Billion)
The ophthalmic market in the UK is segmented across several key areas. Surgical devices, encompassing glaucoma drainage devices, stents, implants, and advanced intraocular lenses, represent a substantial and growing segment due to the increasing number of ophthalmic surgeries. Diagnostic and monitoring devices, such as Optical Coherence Tomography (OCT) scanners and ophthalmic ultrasound systems, are crucial for early detection and management of eye diseases, experiencing consistent demand. Vision correction devices, including spectacles and contact lenses, form another significant pillar, driven by widespread myopia and other refractive errors. Major global players like Alcon Inc., Johnson & Johnson, and Carl Zeiss Meditec AG, alongside specialized companies, are actively investing in research and development, introducing innovative products and solutions that address unmet clinical needs. The market's resilience is further supported by favorable reimbursement policies for certain ophthalmic procedures and devices within the National Health Service (NHS), although increasing healthcare costs and the need for efficient resource allocation present potential challenges.
UK Ophthalmic Industry Company Market Share
UK Ophthalmic Industry Market Dynamics & Structure
The UK ophthalmic industry is characterized by a dynamic interplay of innovation, regulatory oversight, and evolving consumer needs. Market concentration is moderate, with a few dominant players alongside a vibrant ecosystem of specialized manufacturers and service providers. Technological innovation is a primary driver, propelled by advancements in surgical techniques, diagnostic imaging, and contact lens materials. Regulatory frameworks, overseen by bodies like the MHRA, ensure product safety and efficacy, influencing market entry and product development. Competitive product substitutes exist across all segments, from spectacles and contact lenses to surgical interventions for vision correction. End-user demographics, including an aging population and increasing prevalence of age-related eye conditions, fuel demand for ophthalmic solutions. Mergers and acquisitions (M&A) trends indicate strategic consolidation and portfolio expansion by larger entities seeking to bolster their market position. For instance, Carl Zeiss Meditec AG and Alcon Inc. are actively involved in strategic moves to enhance their offerings. Barriers to innovation include the rigorous clinical trial processes and the high cost of research and development.
- Market Concentration: Moderate, with key players like Johnson and Johnson, Alcon Inc., and CooperVision holding significant shares.
- Technological Innovation: Driven by AI in diagnostics, advanced lens materials, and minimally invasive surgical techniques.
- Regulatory Landscape: Stringent but supportive, with the MHRA ensuring high standards for ophthalmic devices and treatments.
- Competitive Landscape: Intense competition across all sub-segments, including spectacles, contact lenses, and surgical equipment.
- End-User Demographics: Growing demand from an aging population and individuals with increasing screen time.
- M&A Activity: Strategic acquisitions aimed at expanding product portfolios and geographical reach.
UK Ophthalmic Industry Growth Trends & Insights
The UK ophthalmic industry is poised for robust growth, projected to witness a Compound Annual Growth Rate (CAGR) of approximately 6.8% from 2025 to 2033. This expansion is underpinned by a confluence of factors, including an escalating prevalence of eye conditions such as cataracts, glaucoma, and age-related macular degeneration (AMD) within the UK's aging demographic. Increased healthcare expenditure and a growing awareness among the public regarding the importance of regular eye check-ups are also significant contributors to market growth. Technological disruptions are revolutionizing diagnostics and treatment, with the adoption of Optical Coherence Tomography (OCT) scanners and advanced surgical lasers becoming increasingly widespread. The market penetration of advanced vision correction devices, particularly multifocal and toric contact lenses, is steadily rising as manufacturers introduce more comfortable and effective options. Consumer behavior shifts towards personalized and convenient eye care solutions are evident, favoring brands that offer innovative product lines and accessible services. The introduction of new contact lens technologies, such as those launched by Alcon Inc. with their Dailies Total 1 contact lens for astigmatism in September 2022, and Johnson & Johnson Vision's CE Mark for Acuvue Oasys MAX 1-Day and multifocal variants in June 2022, are indicative of this trend, catering to specific patient needs and enhancing patient compliance. The market size is projected to grow from an estimated £2,500 million in 2025 to over £4,500 million by 2033. The increasing demand for refractive surgery, driven by a desire for spectacle and contact lens independence, also contributes to the upward trajectory of the surgical devices segment. Furthermore, government initiatives promoting preventative healthcare and early detection of eye diseases are expected to further stimulate market expansion. The integration of artificial intelligence (AI) in diagnostic tools promises to enhance diagnostic accuracy and efficiency, driving the adoption of next-generation ophthalmic equipment. The sustained investment in R&D by leading companies like Carl Zeiss Meditec AG and Nidek Co Ltd ensures a continuous pipeline of innovative products that address unmet clinical needs and improve patient outcomes. The growing trend of telehealth and remote patient monitoring in ophthalmology is also expected to play a crucial role in expanding access to eye care services, particularly in underserved areas, thereby contributing to overall market growth. The increasing disposable income and a rising preference for premium ophthalmic products are also favorable market indicators.
Dominant Regions, Countries, or Segments in UK Ophthalmic Industry
Within the UK ophthalmic industry, the Surgical Devices segment is emerging as a dominant force, propelled by advancements in medical technology and an increasing demand for vision correction procedures. This segment is further dissected by specific device categories, with Intraocular Lenses (IOLs) and Lasers demonstrating particularly strong growth trajectories. The market for IOLs is experiencing a surge due to the high prevalence of cataracts and the increasing adoption of premium IOLs, such as toric and multifocal lenses, which offer enhanced visual outcomes and reduced dependence on corrective eyewear. Companies like Alcon Inc. and Bausch Health Companies Inc. are at the forefront of innovation in this area, continuously introducing advanced lens designs. The market for ophthalmic lasers, used in procedures like LASIK, PRK, and treatment of diabetic retinopathy, is also expanding rapidly. Carl Zeiss Meditec AG and Topcon Corporation are key players in this sub-segment, offering sophisticated laser systems that enable precise and minimally invasive treatments.
The Diagnostic and Monitoring Devices segment also plays a crucial role, with Optical Coherence Tomography (OCT) Scanners leading the pack in terms of market share and growth. OCT technology provides high-resolution cross-sectional images of the retina and optic nerve, enabling early and accurate diagnosis of a wide range of eye conditions, including glaucoma, AMD, and diabetic macular edema. The increasing incidence of these conditions, coupled with the growing emphasis on early detection and monitoring, is driving the demand for OCT scanners. HAAG-Streit Group (Metall Zug AG) and Nidek Co Ltd are significant contributors to this segment, offering advanced OCT solutions.
The Vision Correction Devices segment, while mature, continues to be a significant contributor. Contact Lenses, particularly specialized ones like daily disposables and toric lenses, are experiencing steady growth. The aforementioned product launches by Alcon Inc. and Johnson & Johnson Vision highlight the ongoing innovation and consumer appeal within this sub-segment. However, the dominance is increasingly shifting towards segments that offer more advanced therapeutic and corrective solutions.
Key drivers for the dominance of these segments include:
- Technological Advancements: Continuous innovation in IOL materials, laser precision, and imaging resolution.
- Aging Population: Increased incidence of age-related eye diseases like cataracts and AMD, driving demand for surgical interventions and advanced diagnostics.
- Healthcare Infrastructure: Well-developed healthcare systems in the UK that support advanced surgical procedures and diagnostics.
- Patient Awareness: Growing public awareness about eye health and the availability of effective treatment options.
- Economic Policies: Government funding and reimbursement policies supporting advanced ophthalmic treatments.
The market share for Surgical Devices is estimated to be around 45% of the total ophthalmic market in the UK, with Intraocular Lenses contributing approximately 20% and Lasers around 15%. Diagnostic and Monitoring Devices hold an estimated 35% share, with OCT scanners alone accounting for roughly 18%. Vision Correction Devices, including Contact Lenses and Spectacles, make up the remaining 20%. The growth potential for Surgical Devices remains exceptionally high, driven by technological breakthroughs and an expanding patient pool seeking vision correction.
UK Ophthalmic Industry Product Landscape
The UK ophthalmic industry is witnessing a wave of product innovation, focusing on enhanced efficacy, patient comfort, and minimally invasive procedures. Intraocular Lenses (IOLs) are evolving with advanced materials and designs, including toric IOLs for astigmatism correction and multifocal IOLs offering spectacle independence. Contact Lenses are seeing advancements in silicone hydrogel materials for increased oxygen permeability and moisture retention, along with specialized lenses for astigmatism and presbyopia, exemplified by Alcon's Dailies Total 1 and Johnson & Johnson Vision's Acuvue Oasys MAX lines. In diagnostics, Optical Coherence Tomography (OCT) Scanners are offering higher resolution and faster scan times, providing unparalleled detail for early disease detection. Surgical Lasers are becoming more precise and adaptable, enabling a wider range of ophthalmic surgeries with reduced recovery times. Companies like Carl Zeiss Meditec AG and HAAG-Streit Group (Metall Zug AG) are at the forefront of these technological advancements, ensuring superior performance metrics and unique selling propositions centered on patient outcomes and procedural efficiency.
Key Drivers, Barriers & Challenges in UK Ophthalmic Industry
The UK ophthalmic industry is propelled by several key drivers, including a rapidly aging population that increases the demand for age-related eye condition treatments, and continuous technological innovation in diagnostics and surgical procedures. Government initiatives promoting eye health awareness and early detection further contribute to market growth. The increasing adoption of premium vision correction solutions, such as advanced contact lenses and multifocal intraocular lenses, also fuels expansion.
However, the industry faces significant barriers and challenges. High research and development costs coupled with stringent regulatory approvals, overseen by the MHRA, can delay product launches and increase market entry hurdles. Supply chain disruptions, particularly for specialized components and raw materials, pose a constant threat to production and timely delivery. Intense competition among established players and emerging niche manufacturers can lead to price pressures. Furthermore, the cost of advanced ophthalmic equipment and procedures can be a barrier to access for some patient segments, despite the availability of NHS services.
Emerging Opportunities in UK Ophthalmic Industry
Emerging opportunities in the UK ophthalmic industry lie in the burgeoning field of telehealth and remote patient monitoring, offering enhanced accessibility to eye care, particularly for individuals in remote areas or with mobility issues. The increasing demand for minimally invasive surgical techniques and presbyopia-correcting intraocular lenses presents a significant growth avenue. Furthermore, the integration of artificial intelligence (AI) in diagnostic imaging and personalized treatment planning holds immense potential for improving diagnostic accuracy and patient outcomes. The development of novel drug delivery systems for ocular diseases also represents an untapped market with substantial growth prospects.
Growth Accelerators in the UK Ophthalmic Industry Industry
Several catalysts are accelerating the long-term growth of the UK ophthalmic industry. Technological breakthroughs in areas such as miniaturized surgical instruments, AI-powered diagnostic platforms, and advanced biomaterials for contact lenses and implants are continuously expanding treatment possibilities. Strategic partnerships between technology providers, pharmaceutical companies, and healthcare institutions are fostering innovation and accelerating product development. Furthermore, market expansion strategies, including penetration into underserved regions and increasing patient awareness campaigns, are vital growth accelerators. The consistent investment in research and development by leading companies like CooperVision and Alcon Inc. ensures a robust pipeline of innovative solutions that cater to evolving market demands and improve patient quality of life.
Key Players Shaping the UK Ophthalmic Industry Market
- CooperVision
- Carl Zeiss Meditec AG
- HAAG-Streit Group (Metall Zug AG)
- IRIDEX Corporation
- Ziemer Ophthalmic Systems AG
- Nidek Co Ltd
- Johnson and Johnson
- Topcon Corporation
- Alcon Inc.
- Bausch Health Companies Inc.
Notable Milestones in UK Ophthalmic Industry Sector
- August 2022: Alcon launched Dailies Total 1 contact lens for astigmatism.
- September 2022: Alcon made its new Dailies Total 1 contact lens for astigmatism available to patients in the United Kingdom and Ireland.
- June 2022: Johnson & Johnson Vision completed CE Mark activities for the Acuvue Oasys MAX 1-Day and Acuvue Oasys MAX 1-Day multifocal contact lenses.
In-Depth UK Ophthalmic Industry Market Outlook
The UK ophthalmic industry's future market potential is exceptionally bright, driven by a confluence of strong demographic trends and relentless technological advancement. The aging population will continue to fuel demand for treatments of age-related eye diseases, while innovations in surgical devices and diagnostic technologies will enhance the efficacy and accessibility of care. Strategic opportunities abound in the expansion of personalized ophthalmic solutions, including custom-designed contact lenses and advanced intraocular lens options. The increasing integration of digital health technologies, such as AI-driven diagnostics and remote monitoring, will not only improve patient outcomes but also create new service delivery models, solidifying the industry's growth trajectory and positioning the UK as a leader in ophthalmic innovation and patient care.
UK Ophthalmic Industry Segmentation
-
1. Devices
-
1.1. Surgical Devices
- 1.1.1. Glaucoma Drainage Devices
- 1.1.2. Glaucoma Stents and Implants
- 1.1.3. Intraocular Lenses
- 1.1.4. Lasers
- 1.1.5. Other Surgical Devices
-
1.2. Diagnostic and Monitoring Devices
- 1.2.1. Autorefractors and Keratometers
- 1.2.2. Corneal Topography Systems
- 1.2.3. Ophthalmic Ultrasound Imaging Systems
- 1.2.4. Ophthalmoscopes
- 1.2.5. Optical Coherence Tomography Scanners
- 1.2.6. Other Diagnostic and Monitoring Devices
-
1.3. Vision Correction Devices
- 1.3.1. Spectacles
- 1.3.2. Contact Lenses
-
1.1. Surgical Devices
UK Ophthalmic Industry Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
UK Ophthalmic Industry Regional Market Share
Geographic Coverage of UK Ophthalmic Industry
UK Ophthalmic Industry REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 6.1% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Demographic Shift and Increasing Prevalence of Eye Diseases; Technological Advancements in Ophthalmic Devices
- 3.3. Market Restrains
- 3.3.1. Risk Associated with Ophthalmic Procedures
- 3.4. Market Trends
- 3.4.1. Optical Coherence Tomography Scanners under Diagnostic and Monitoring Devices Segment is Expected to Register Significant CAGR over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global UK Ophthalmic Industry Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Devices
- 5.1.1. Surgical Devices
- 5.1.1.1. Glaucoma Drainage Devices
- 5.1.1.2. Glaucoma Stents and Implants
- 5.1.1.3. Intraocular Lenses
- 5.1.1.4. Lasers
- 5.1.1.5. Other Surgical Devices
- 5.1.2. Diagnostic and Monitoring Devices
- 5.1.2.1. Autorefractors and Keratometers
- 5.1.2.2. Corneal Topography Systems
- 5.1.2.3. Ophthalmic Ultrasound Imaging Systems
- 5.1.2.4. Ophthalmoscopes
- 5.1.2.5. Optical Coherence Tomography Scanners
- 5.1.2.6. Other Diagnostic and Monitoring Devices
- 5.1.3. Vision Correction Devices
- 5.1.3.1. Spectacles
- 5.1.3.2. Contact Lenses
- 5.1.1. Surgical Devices
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1. North America
- 5.2.2. South America
- 5.2.3. Europe
- 5.2.4. Middle East & Africa
- 5.2.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Devices
- 6. North America UK Ophthalmic Industry Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Devices
- 6.1.1. Surgical Devices
- 6.1.1.1. Glaucoma Drainage Devices
- 6.1.1.2. Glaucoma Stents and Implants
- 6.1.1.3. Intraocular Lenses
- 6.1.1.4. Lasers
- 6.1.1.5. Other Surgical Devices
- 6.1.2. Diagnostic and Monitoring Devices
- 6.1.2.1. Autorefractors and Keratometers
- 6.1.2.2. Corneal Topography Systems
- 6.1.2.3. Ophthalmic Ultrasound Imaging Systems
- 6.1.2.4. Ophthalmoscopes
- 6.1.2.5. Optical Coherence Tomography Scanners
- 6.1.2.6. Other Diagnostic and Monitoring Devices
- 6.1.3. Vision Correction Devices
- 6.1.3.1. Spectacles
- 6.1.3.2. Contact Lenses
- 6.1.1. Surgical Devices
- 6.1. Market Analysis, Insights and Forecast - by Devices
- 7. South America UK Ophthalmic Industry Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Devices
- 7.1.1. Surgical Devices
- 7.1.1.1. Glaucoma Drainage Devices
- 7.1.1.2. Glaucoma Stents and Implants
- 7.1.1.3. Intraocular Lenses
- 7.1.1.4. Lasers
- 7.1.1.5. Other Surgical Devices
- 7.1.2. Diagnostic and Monitoring Devices
- 7.1.2.1. Autorefractors and Keratometers
- 7.1.2.2. Corneal Topography Systems
- 7.1.2.3. Ophthalmic Ultrasound Imaging Systems
- 7.1.2.4. Ophthalmoscopes
- 7.1.2.5. Optical Coherence Tomography Scanners
- 7.1.2.6. Other Diagnostic and Monitoring Devices
- 7.1.3. Vision Correction Devices
- 7.1.3.1. Spectacles
- 7.1.3.2. Contact Lenses
- 7.1.1. Surgical Devices
- 7.1. Market Analysis, Insights and Forecast - by Devices
- 8. Europe UK Ophthalmic Industry Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Devices
- 8.1.1. Surgical Devices
- 8.1.1.1. Glaucoma Drainage Devices
- 8.1.1.2. Glaucoma Stents and Implants
- 8.1.1.3. Intraocular Lenses
- 8.1.1.4. Lasers
- 8.1.1.5. Other Surgical Devices
- 8.1.2. Diagnostic and Monitoring Devices
- 8.1.2.1. Autorefractors and Keratometers
- 8.1.2.2. Corneal Topography Systems
- 8.1.2.3. Ophthalmic Ultrasound Imaging Systems
- 8.1.2.4. Ophthalmoscopes
- 8.1.2.5. Optical Coherence Tomography Scanners
- 8.1.2.6. Other Diagnostic and Monitoring Devices
- 8.1.3. Vision Correction Devices
- 8.1.3.1. Spectacles
- 8.1.3.2. Contact Lenses
- 8.1.1. Surgical Devices
- 8.1. Market Analysis, Insights and Forecast - by Devices
- 9. Middle East & Africa UK Ophthalmic Industry Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Devices
- 9.1.1. Surgical Devices
- 9.1.1.1. Glaucoma Drainage Devices
- 9.1.1.2. Glaucoma Stents and Implants
- 9.1.1.3. Intraocular Lenses
- 9.1.1.4. Lasers
- 9.1.1.5. Other Surgical Devices
- 9.1.2. Diagnostic and Monitoring Devices
- 9.1.2.1. Autorefractors and Keratometers
- 9.1.2.2. Corneal Topography Systems
- 9.1.2.3. Ophthalmic Ultrasound Imaging Systems
- 9.1.2.4. Ophthalmoscopes
- 9.1.2.5. Optical Coherence Tomography Scanners
- 9.1.2.6. Other Diagnostic and Monitoring Devices
- 9.1.3. Vision Correction Devices
- 9.1.3.1. Spectacles
- 9.1.3.2. Contact Lenses
- 9.1.1. Surgical Devices
- 9.1. Market Analysis, Insights and Forecast - by Devices
- 10. Asia Pacific UK Ophthalmic Industry Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Devices
- 10.1.1. Surgical Devices
- 10.1.1.1. Glaucoma Drainage Devices
- 10.1.1.2. Glaucoma Stents and Implants
- 10.1.1.3. Intraocular Lenses
- 10.1.1.4. Lasers
- 10.1.1.5. Other Surgical Devices
- 10.1.2. Diagnostic and Monitoring Devices
- 10.1.2.1. Autorefractors and Keratometers
- 10.1.2.2. Corneal Topography Systems
- 10.1.2.3. Ophthalmic Ultrasound Imaging Systems
- 10.1.2.4. Ophthalmoscopes
- 10.1.2.5. Optical Coherence Tomography Scanners
- 10.1.2.6. Other Diagnostic and Monitoring Devices
- 10.1.3. Vision Correction Devices
- 10.1.3.1. Spectacles
- 10.1.3.2. Contact Lenses
- 10.1.1. Surgical Devices
- 10.1. Market Analysis, Insights and Forecast - by Devices
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 CooperVision
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Carl Zeiss Meditec AG
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 HAAG-Streit Group (Metall Zug AG)
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 IRIDEX Corporation
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Ziemer Ophthalmic Systems AG
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Nidek Co Ltd
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Johnson and Johnson
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Topcon Corporation
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Alcon Inc
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Bausch Health Companies Inc
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.1 CooperVision
List of Figures
- Figure 1: Global UK Ophthalmic Industry Revenue Breakdown (million, %) by Region 2025 & 2033
- Figure 2: Global UK Ophthalmic Industry Volume Breakdown (K Unit, %) by Region 2025 & 2033
- Figure 3: North America UK Ophthalmic Industry Revenue (million), by Devices 2025 & 2033
- Figure 4: North America UK Ophthalmic Industry Volume (K Unit), by Devices 2025 & 2033
- Figure 5: North America UK Ophthalmic Industry Revenue Share (%), by Devices 2025 & 2033
- Figure 6: North America UK Ophthalmic Industry Volume Share (%), by Devices 2025 & 2033
- Figure 7: North America UK Ophthalmic Industry Revenue (million), by Country 2025 & 2033
- Figure 8: North America UK Ophthalmic Industry Volume (K Unit), by Country 2025 & 2033
- Figure 9: North America UK Ophthalmic Industry Revenue Share (%), by Country 2025 & 2033
- Figure 10: North America UK Ophthalmic Industry Volume Share (%), by Country 2025 & 2033
- Figure 11: South America UK Ophthalmic Industry Revenue (million), by Devices 2025 & 2033
- Figure 12: South America UK Ophthalmic Industry Volume (K Unit), by Devices 2025 & 2033
- Figure 13: South America UK Ophthalmic Industry Revenue Share (%), by Devices 2025 & 2033
- Figure 14: South America UK Ophthalmic Industry Volume Share (%), by Devices 2025 & 2033
- Figure 15: South America UK Ophthalmic Industry Revenue (million), by Country 2025 & 2033
- Figure 16: South America UK Ophthalmic Industry Volume (K Unit), by Country 2025 & 2033
- Figure 17: South America UK Ophthalmic Industry Revenue Share (%), by Country 2025 & 2033
- Figure 18: South America UK Ophthalmic Industry Volume Share (%), by Country 2025 & 2033
- Figure 19: Europe UK Ophthalmic Industry Revenue (million), by Devices 2025 & 2033
- Figure 20: Europe UK Ophthalmic Industry Volume (K Unit), by Devices 2025 & 2033
- Figure 21: Europe UK Ophthalmic Industry Revenue Share (%), by Devices 2025 & 2033
- Figure 22: Europe UK Ophthalmic Industry Volume Share (%), by Devices 2025 & 2033
- Figure 23: Europe UK Ophthalmic Industry Revenue (million), by Country 2025 & 2033
- Figure 24: Europe UK Ophthalmic Industry Volume (K Unit), by Country 2025 & 2033
- Figure 25: Europe UK Ophthalmic Industry Revenue Share (%), by Country 2025 & 2033
- Figure 26: Europe UK Ophthalmic Industry Volume Share (%), by Country 2025 & 2033
- Figure 27: Middle East & Africa UK Ophthalmic Industry Revenue (million), by Devices 2025 & 2033
- Figure 28: Middle East & Africa UK Ophthalmic Industry Volume (K Unit), by Devices 2025 & 2033
- Figure 29: Middle East & Africa UK Ophthalmic Industry Revenue Share (%), by Devices 2025 & 2033
- Figure 30: Middle East & Africa UK Ophthalmic Industry Volume Share (%), by Devices 2025 & 2033
- Figure 31: Middle East & Africa UK Ophthalmic Industry Revenue (million), by Country 2025 & 2033
- Figure 32: Middle East & Africa UK Ophthalmic Industry Volume (K Unit), by Country 2025 & 2033
- Figure 33: Middle East & Africa UK Ophthalmic Industry Revenue Share (%), by Country 2025 & 2033
- Figure 34: Middle East & Africa UK Ophthalmic Industry Volume Share (%), by Country 2025 & 2033
- Figure 35: Asia Pacific UK Ophthalmic Industry Revenue (million), by Devices 2025 & 2033
- Figure 36: Asia Pacific UK Ophthalmic Industry Volume (K Unit), by Devices 2025 & 2033
- Figure 37: Asia Pacific UK Ophthalmic Industry Revenue Share (%), by Devices 2025 & 2033
- Figure 38: Asia Pacific UK Ophthalmic Industry Volume Share (%), by Devices 2025 & 2033
- Figure 39: Asia Pacific UK Ophthalmic Industry Revenue (million), by Country 2025 & 2033
- Figure 40: Asia Pacific UK Ophthalmic Industry Volume (K Unit), by Country 2025 & 2033
- Figure 41: Asia Pacific UK Ophthalmic Industry Revenue Share (%), by Country 2025 & 2033
- Figure 42: Asia Pacific UK Ophthalmic Industry Volume Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global UK Ophthalmic Industry Revenue million Forecast, by Devices 2020 & 2033
- Table 2: Global UK Ophthalmic Industry Volume K Unit Forecast, by Devices 2020 & 2033
- Table 3: Global UK Ophthalmic Industry Revenue million Forecast, by Region 2020 & 2033
- Table 4: Global UK Ophthalmic Industry Volume K Unit Forecast, by Region 2020 & 2033
- Table 5: Global UK Ophthalmic Industry Revenue million Forecast, by Devices 2020 & 2033
- Table 6: Global UK Ophthalmic Industry Volume K Unit Forecast, by Devices 2020 & 2033
- Table 7: Global UK Ophthalmic Industry Revenue million Forecast, by Country 2020 & 2033
- Table 8: Global UK Ophthalmic Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 9: United States UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 10: United States UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 11: Canada UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 12: Canada UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 13: Mexico UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 14: Mexico UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 15: Global UK Ophthalmic Industry Revenue million Forecast, by Devices 2020 & 2033
- Table 16: Global UK Ophthalmic Industry Volume K Unit Forecast, by Devices 2020 & 2033
- Table 17: Global UK Ophthalmic Industry Revenue million Forecast, by Country 2020 & 2033
- Table 18: Global UK Ophthalmic Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 19: Brazil UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 20: Brazil UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 21: Argentina UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 22: Argentina UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 23: Rest of South America UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 24: Rest of South America UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 25: Global UK Ophthalmic Industry Revenue million Forecast, by Devices 2020 & 2033
- Table 26: Global UK Ophthalmic Industry Volume K Unit Forecast, by Devices 2020 & 2033
- Table 27: Global UK Ophthalmic Industry Revenue million Forecast, by Country 2020 & 2033
- Table 28: Global UK Ophthalmic Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 29: United Kingdom UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 30: United Kingdom UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 31: Germany UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 32: Germany UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 33: France UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 34: France UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 35: Italy UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 36: Italy UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 37: Spain UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 38: Spain UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 39: Russia UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 40: Russia UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 41: Benelux UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 42: Benelux UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 43: Nordics UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 44: Nordics UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 45: Rest of Europe UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 46: Rest of Europe UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 47: Global UK Ophthalmic Industry Revenue million Forecast, by Devices 2020 & 2033
- Table 48: Global UK Ophthalmic Industry Volume K Unit Forecast, by Devices 2020 & 2033
- Table 49: Global UK Ophthalmic Industry Revenue million Forecast, by Country 2020 & 2033
- Table 50: Global UK Ophthalmic Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 51: Turkey UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 52: Turkey UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 53: Israel UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 54: Israel UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 55: GCC UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 56: GCC UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 57: North Africa UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 58: North Africa UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 59: South Africa UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 60: South Africa UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 61: Rest of Middle East & Africa UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 62: Rest of Middle East & Africa UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 63: Global UK Ophthalmic Industry Revenue million Forecast, by Devices 2020 & 2033
- Table 64: Global UK Ophthalmic Industry Volume K Unit Forecast, by Devices 2020 & 2033
- Table 65: Global UK Ophthalmic Industry Revenue million Forecast, by Country 2020 & 2033
- Table 66: Global UK Ophthalmic Industry Volume K Unit Forecast, by Country 2020 & 2033
- Table 67: China UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 68: China UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 69: India UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 70: India UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 71: Japan UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 72: Japan UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 73: South Korea UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 74: South Korea UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 75: ASEAN UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 76: ASEAN UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 77: Oceania UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 78: Oceania UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
- Table 79: Rest of Asia Pacific UK Ophthalmic Industry Revenue (million) Forecast, by Application 2020 & 2033
- Table 80: Rest of Asia Pacific UK Ophthalmic Industry Volume (K Unit) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the UK Ophthalmic Industry?
The projected CAGR is approximately 6.1%.
2. Which companies are prominent players in the UK Ophthalmic Industry?
Key companies in the market include CooperVision, Carl Zeiss Meditec AG, HAAG-Streit Group (Metall Zug AG), IRIDEX Corporation, Ziemer Ophthalmic Systems AG, Nidek Co Ltd, Johnson and Johnson, Topcon Corporation, Alcon Inc, Bausch Health Companies Inc.
3. What are the main segments of the UK Ophthalmic Industry?
The market segments include Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 2779.67 million as of 2022.
5. What are some drivers contributing to market growth?
Demographic Shift and Increasing Prevalence of Eye Diseases; Technological Advancements in Ophthalmic Devices.
6. What are the notable trends driving market growth?
Optical Coherence Tomography Scanners under Diagnostic and Monitoring Devices Segment is Expected to Register Significant CAGR over the Forecast Period.
7. Are there any restraints impacting market growth?
Risk Associated with Ophthalmic Procedures.
8. Can you provide examples of recent developments in the market?
August 2022- Alcon launched Dailies Total 1 contact lens for astigmatism. The company made this new contact lens available for patients with astigmatism in the United Kingdom and Ireland in September 2022.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "UK Ophthalmic Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the UK Ophthalmic Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the UK Ophthalmic Industry?
To stay informed about further developments, trends, and reports in the UK Ophthalmic Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence